Related Experiment Videos
Bilateral renal cell carcinoma with metastasis to thyroid
M A Hudson1, L R Kavoussi, W J Catalona
1Jewish Hospital, Washington University Medical Center, St. Louis, Missouri.
Urology
|February 1, 1991
Summary
Bilateral synchronous renal cell carcinoma with widespread metastases was surgically removed and treated with adjuvant gamma interferon. The patient maintains excellent health 16 months post-diagnosis, indicating a positive prognosis for aggressive kidney cancer.
Area of Science:
- Oncology
- Surgical Oncology
- Immunotherapy
Background:
- Bilateral synchronous renal cell carcinoma (RCC) is a rare clinical presentation.
- Metastatic spread of RCC to regional lymph nodes and distant sites like the thyroid gland presents significant treatment challenges.
Observation:
- A patient presented with bilateral synchronous renal cell carcinomas.
- The cancer had metastasized to regional lymph nodes and subsequently to the thyroid gland.
- The patient had a substantial tumor burden at the time of diagnosis.
Findings:
- The patient underwent aggressive surgical extirpation of the tumors.
- Adjuvant therapy with gamma interferon was administered post-surgery.
- Sixteen months after diagnosis, the patient maintained an excellent performance status.
Implications:
- Aggressive surgical management combined with adjuvant immunotherapy may be effective in managing advanced, metastatic bilateral renal cell carcinoma.
- Early and comprehensive treatment can lead to favorable long-term outcomes even in cases with extensive tumor burden.
- This case highlights the potential of multimodal treatment strategies in improving patient prognosis for rare and aggressive cancers.